Prof DAVID WERRING: Why the AztraZeneca jab is worth the risk

[ad_1] As a clinical neurologist, I must balance on a daily basis the risks and benefits of interventions in often complex, high-risk situations. While these are specialised decisions about the net benefit of a particular course of action, they are the stuff